Dr. Sandeep Jain, MBBS, is a board-certified medical oncologist and hematologist specializing in internal medicine. He has been a member of the American Society of Clinical Oncology (ASCO) and the American Society of Hematology since 2012 and is a Fellow of the Royal College of Physicians in the UK. Dr. Jain is dedicated to providing personalized care to his patients, offering cutting-edge cancer treatments and comprehensive supportive care. He is committed to guiding patients through their treatment journey, empowering them to live fulfilling and productive lives following a cancer diagnosis.
With a focus on research and publications, Dr. Jain has contributed to various peer-reviewed journal articles in medical oncology and hematology. His work includes studies on myeloablative versus reduced-intensity conditioning for chronic myeloid leukemia, as well as the molecular characteristics of malignant plasma cells in multiple myeloma. Additionally, Dr. Jain has been involved in clinical trials investigating the role of aspirin as adjuvant therapy for breast cancer and evaluating the use of immunotherapy in patients with colon cancer. He has presented his research at national conferences and contributed to medical literature through poster presentations and peer review. Dr. Jain is dedicated to advancing the field of oncology and providing the best possible care for his patients.
